3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
7
Phase 1
7
Phase NA
4
Phase EARLY_PHASE1
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, B-Cell
6
Recurrence
4
Lymphoma, Mantle-Cell
3
Lymphoma
3
Burkitt Lymphoma
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, B-Cell
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
192
Methotrexate
106
Cytarabine
86
fludarabine phosphate
80
Busulfan
71
Tacrolimus
70
Peripheral Blood Stem Cell Transplantation
69
Mycophenolic Acid
69
Whole-Body Irradiation
68
Vincristine
67
fludarabine
61
Filgrastim
61
Etoposide
59
Dexamethasone
54
Melphalan
52
Radiotherapy
47
Rituximab
46
Cyclosporine
46
Doxorubicin
38
Antilymphocyte Serum
37
Thiotepa
35
Prednisone
35
Mercaptopurine
35
Granulocyte Colony-Stimulating Factor
35
blinatumomab
33
pegaspargase
27
Methylprednisolone
27
Daunorubicin
26
Clofarabine
26
Asparaginase
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Immunotherapy, Adoptive
×
Clear all
NCT01685606
2022-03-04
273
Brown University
Phase 2
Terminated
6 enrolled
7 charts